RPRX — Royalty Pharma Share News
0.000.00%
Last trade - 00:00- $36.72bn
- $47.80bn
- $2.38bn
Brief: Royalty Pharma Announces Upcoming Investor Day
U.S. STOCKS ON THE MOVE-Chefs' Warehouse, Aptose Biosciences, Electromed
U.S. STOCKS ON THE MOVE-PPG Industries, CME Group, WiSA Technologies
Royalty Pharma falls after investing $250 mln in Biogen's lupus treatment
Royalty Pharma PLC reports results for the quarter ended December 31 - Earnings Summary
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-IonQ, Lennar, GH Research
Royalty Pharma rises on $1.1 bln deal to acquire its external manager
Royalty Pharma simplifies corporate structure with $1.1 bln deal (updated)
Brief: Royalty Pharma To Highlight Accomplishments And Provide Business Update At 43rd Annual J.P. Morgan Healthcare Conference
Royalty Pharma simplifies corporate structure with $1.1 bln deal
Brief: Royalty Pharma To Acquire Royalty Interest In Geron’S RYTELO For $125 Mln
Brief: Royalty Pharma Reports Third Quarter 2024 Results
Brief: Royalty Pharma And Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement For Niktimvo
Royalty Pharma PLC reports results for the quarter ended in June - Earnings Summary
Royalty Pharma PLC expected to post earnings of 99 cents a share - Earnings Preview
Brief: Royalty Pharma Appoints Molly Sawaya As Head Of Human Capital
Brief: PTC Therapeutics To Sell Half Of Retained Royalties On Roche's Evrysdi To Royalty Pharma Unit